Bartronics India Partners with Huwel Life Sciences to Deliver Affordable Diagnostics

Bartronics India Limited (BIL) has announced a strategic investment of up to 50 crore in Huwel Life Sciences Pvt. Ltd, a molecular diagnostics innovator. BIL will acquire a 15% equity stake in Huwel, bringing together its scaling expertise with Huwel’s innovation capabilities. The partnership aims to accelerate India’s health goals and drive market growth for Huwel’s affordable TB solution, Quantiplus® TB Fast Detection Kit, which is approved by ICMR and launched by the Union Health Minister. This kit is the only open-system, affordable RT-PCR solution for TB confirmatory testing in India. BIL will take the lead in identifying opportunities, negotiating terms, and securing orders, while Huwel will continue to drive R&D and product adoption worldwide. This partnership guarantees assured revenue for BIL and aims to position India as a global hub for life sciences innovation and manufacturing.